Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia).
Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia).
复制标题
DOI:
10.1371/journal.pone.0005394
复制
发表时间:
2009
期刊:
影响因子:
3.7
通讯作者:
Tokunaga K
中科院分区:
文献类型:
--
作者:
Miyagawa T;Honda M;Kawashima M;Shimada M;Tanaka S;Honda Y;Tokunaga K
SNP rs5770917 located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype were previously identified as susceptibility loci for narcolepsy with cataplexy. This study was conducted in order to investigate whether these genetic markers are associated with Japanese CNS hypersomnias (essential hypersomnia: EHS) other than narcolepsy with cataplexy. EHS was significantly associated with SNP rs5770917 (Pallele = 3.6×10−3; OR = 1.56; 95% c.i.: 1.12–2.15) and HLA-DRB1*1501-DQB1*0602 haplotype (P positivity = 9.2×10−11; OR = 3.97; 95% c.i.: 2.55–6.19). No interaction between the two markers (SNP rs5770917 and HLA-DRB1*1501-DQB1*0602 haplotype) was observed in EHS. CPT1B, CHKB and HLA are candidates for susceptibility to CNS hypersomnias (EHS), as well as narcolepsy with cataplexy.
登录
查看更多内容
影响因子:
11.9
作者:
Komada, Y;Inoue, Y;Honda, Y
通讯作者:
Honda, Y
影响因子:
64.5
作者:
Chemelli, RM;Willie, JT;Yanagisawa, M
通讯作者:
Yanagisawa, M
影响因子:
5.6
作者:
Anderson, Kirstie N.;Pilsworth, Samantha;Shneerson, John M.
通讯作者:
Shneerson, John M.
影响因子:
5.6
作者:
Hong, Seung-Chul;Lin, Ling;Mignot, Emmanuel
通讯作者:
Mignot, Emmanuel
影响因子:
30.8
作者:
Tafti, M;Petit, B;Franken, P
通讯作者:
Franken, P